Evidence map›Paper›PMID 36447427›Full record

ReviewJournal of clinical laboratory analysis2022

Circulating microbiota and metabolites: Insights into cardiovascular diseases.

Ikram Khan, Imran Khan, Muhammad Usman, Zhang Xiao Wei, Xie Ping, Sarmir Khan, Feroz Khan, Zhou Jianye, Li Zhiqiang, An Lizhe

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical laboratory analysis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Ikram KhanDepartment of Microbiology, School of Life Sciences, Lanzhou University, Lanzhou, Gansu, China.ORCID https://orcid.org/0000-0002-5233-1480
Imran KhanDepartment of Microbiology, Khyber Medical University Peshawar, Peshawar, Khyber Pakhtunkhwa, Pakistan.
Muhammad UsmanState Key Laboratory of Grassland Agro-ecosystem, Key Laboratory of Grassland Livestock Industry Innovation, Ministry of Agriculture and Ruler Affairs, Collegeof Pastoral Agriculture Sciences and Technology, Lanzhou University, Lanzhou, Gansu, China.
Zhang Xiao WeiDepartment of Cardiology, Lanzhou University Second Hospital, Lanzhou, Gansu, China.
Xie PingDepartment of Cardiology, Gansu Provincial Hospital, Lanzhou, China.
Sarmir KhanDepartment of Reproductive Medicine, Academy of Medical Sciences, The First Affiliated Hospital of Zheng University, Zhengzhou, Henan, China.
Feroz KhanDepartment of Zoology, Wildlife, and Fisheries, PirMehr Ali Shah Arid Agriculture University, Rawalpindi, Pakistan.
Zhou JianyeSchool of Stomatology, Northwest Minzu University, Lanzhou, Gansu, China.
Li ZhiqiangSchool of Stomatology, Northwest Minzu University, Lanzhou, Gansu, China.
An LizheDepartment of Microbiology, School of Life Sciences, Lanzhou University, Lanzhou, Gansu, China.
Minzu University of China · CNLanzhou University · CNFirst Affiliated Hospital of Zhengzhou University · CNGansu Provincial Hospital · CNLanzhou University Second Hospital · CNPir Mehr Ali Shah Arid Agriculture University · PK

Funding

Lizhi Qiang 31760159
6 · The paper itself

Abstract

backgroundIn almost every country, cardiovascular diseases are the major cause of death, which are responsible for 17.7 million deaths worldwide, or 54% of all deaths. However, the latest evidence has shown that non-communicable diseases such as obesity, diabetes, and cardiovascular events are significantly influenced by the blood microbiota and circulating metabolites.

methodsWe searched online databases for the most recent related papers through the comprehensive international databases of the Institute of PubMed/ MEDLINE, ISI/WOS, and Scopus up to August 2022, using MESH terms and the related keywords in the English language. Considering the titles and abstracts, unrelated studies were excluded. The full texts of the remained studies were evaluated by authors, independently. Then, the studies' findings were assessed and reported.

resultsThe study demonstrated that the bacterial profiles of patients with cardiovascular diseases and healthy individuals are significantly different. The diseased patients showed a significantly high abundance of phylum Proteobacteria, an important Proteobacterial component known as lipopolysaccharides that has been linked to the pathogenesis of cardiovascular disease, while phylum Firmicutes were found in healthy individuals. It suggests that Proteobacteria has a direct role in the onset of cardiovascular disease.

conclusionWe focused on the blood bacterial composition and circulating microbial metabolites in their relationship with the etiology and onset of cardiovascular disease. However, the various genera and species in the results reported were not always identical. Therefore, the microbial community structure of blood was more complicated and thus required a more in-depth exploration.

Indexed as

Cardiovascular DiseasesMicrobiotaBacteriaHumansbacteriablood microbiotacardiovascular diseasescirculating metabolitesnon-communicable diseases

Identifiers

PMID36447427
PMCPMC9757012
OpenAlexW4310463904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.